CRISPR Therapy Eliminates 50% of Head and Neck Tumors in Preclinical Study

Written By Head and Neck Cancer Support Network

Researchers at Tel Aviv University have demonstrated that CRISPR gene editing can effectively eliminate head and neck tumours by directly injecting lipid nanoparticles (LNPs) containing CRISPR components into the tumours. In a study published in Advanced Science, they reported that 50% of treated tumours vanished after 84 days, marking a significant advance in precision cancer therapy. Read more here…https://www.insideprecisionmedicine.com/topics/oncology/crispr-therapy-elim

Head and Neck Cancer Support Network
Previous

Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy
Next

First FDA-Approved Robot-Assisted Microsurgery for Head and Neck Cancer Performed at Cedars-Sinai